| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 24 |
| 1 | METHYLPREDNISOLONE | 15 |
| 2 | PREDNISOLONE | 15 |
| 3 | PREDNISOLONE ORAL | 15 |
| 4 | PREDNISOLONE ORAL SOLUTION | 15 |
| 5 | ACETAMINOPHEN | 12 |
| 6 | FUROSEMIDE | 12 |
| 7 | ACETAMINOPHEN 500MG | 10 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 10 |
| 9 | PAIN RELIEVER | 10 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 40 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 24 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 3 | Benzodiazepine [EPC] | 16 |
| 4 | Loop Diuretic [EPC] | 13 |
| 5 | Alkylating Drug [EPC] | 11 |
| 6 | Osmotic Laxative [EPC] | 11 |
| 7 | Janus Kinase Inhibitor [EPC] | 10 |
| 8 | Mood Stabilizer [EPC] | 10 |
| 9 | Kinase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 24 | 0.0012 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 5 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 4 | 0.0003 |
| 6 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 7 | Nonergot Dopamine Agonist [EPC] | 4 | 0.0003 |
| 8 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 9 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |